SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,533,000 | -20.0% | 303,000 | -13.4% | 0.91% | -37.7% |
| Q3 2019 | $3,168,000 | +96.0% | 350,000 | +133.3% | 1.46% | +144.4% |
| Q2 2019 | $1,616,000 | +253.6% | 150,000 | +212.5% | 0.60% | +254.4% |
| Q1 2019 | $457,000 | +5.8% | 48,000 | 0.0% | 0.17% | -36.9% |
| Q4 2018 | $432,000 | -70.5% | 48,000 | -57.5% | 0.27% | -61.5% |
| Q3 2018 | $1,464,000 | -8.8% | 113,000 | 0.0% | 0.70% | +13.0% |
| Q2 2018 | $1,605,000 | +59.9% | 113,000 | +113.2% | 0.62% | +57.1% |
| Q1 2018 | $1,004,000 | -66.9% | 53,000 | -71.4% | 0.39% | -63.4% |
| Q4 2017 | $3,034,000 | -25.9% | 185,000 | -32.2% | 1.07% | -32.9% |
| Q3 2017 | $4,095,000 | – | 273,000 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |